Stifel

Presenting Companies Announced for the 2024 ICR Conference

Retrieved on: 
星期二, 十一月 28, 2023
Other Professional Services, Business, Finance, Consulting, Media, Asset Management, Professional Services, Other Communications, Public Relations, Investor Relations, Marketing, Digital Marketing, Advertising, Communications, Content Marketing, The Ritz-Carlton Hotel Company, RSM US, Ropes & Gray, TD Securities, UBS, Citigroup, HSBC, BMO, LLP, Weil, Gotshal & Manges, Vinson & Elkins, JPMorgan Chase, Morgan Stanley, Goldman Sachs, Truist, Canaccord Genuity, Oppenheimer Holdings, Conference, BofA Securities, Barclays, Deutsche Bank, Privately held company, Stephens Inc., Hearing, Wells Fargo, RBC, Kirkland & Ellis, KeyBank, ICR, Stifel, JW Marriott Hotels

ICR , a leading strategic communications and advisory firm, today announced its preliminary list of presenting companies for the 26th ICR Conference , one of the largest growth company investment conferences of the year.

Key Points: 
  • ICR , a leading strategic communications and advisory firm, today announced its preliminary list of presenting companies for the 26th ICR Conference , one of the largest growth company investment conferences of the year.
  • “The 2024 ICR Conference will feature another excellent lineup of innovative growth companies at the forefront of their industries,” said Tom Ryan, Chief Executive Officer, ICR.
  • “We are looking forward to hearing from public and private company management teams who will share their views and insights for driving growth and value creation in the year ahead and beyond.”
    To view the preliminary list of presenting companies at the 2024 ICR Conference, please visit: ICR Conference 2024 Presenting Companies
    ICR previously announced that its initial sponsors in 2024 will include Baird, Barclays, BMO, BofA Securities, Canaccord Genuity, Citi, D.A.
  • To request an invitation to attend or present at the 2024 ICR Conference, please visit https://icrconference.com/contact/request-invitation/ .

TJC Announces Agreement to Acquire Global Transport Solutions

Retrieved on: 
星期一, 十一月 27, 2023
Maritime, Logistics, Supply Chain Management, Professional Services, Transport, Asset Management, Acquisition, Financial adviser, Organization, Kirkland & Ellis, Culture, TJC, Stifel, GTS, Growth, Fine chemical, Management

TJC, L.P. (“TJC”) has entered into a definitive agreement to acquire Global Transport Solutions Topholding B.V. (“GTS” or the “Company”), an international logistics service provider specializing in supply chain and forwarding solutions for the maritime industry.

Key Points: 
  • TJC, L.P. (“TJC”) has entered into a definitive agreement to acquire Global Transport Solutions Topholding B.V. (“GTS” or the “Company”), an international logistics service provider specializing in supply chain and forwarding solutions for the maritime industry.
  • Operating under the brands Marinetrans and Best Global Logistics, GTS has a robust geographical presence across all continents.
  • As a management team, we are thrilled to partner with the TJC team in this next phase.”
    The acquisition reinforces the strong dedication to both GTS’s clients and its staff.
  • Stifel served as Financial Advisor and Kirkland & Ellis LLP and Loyens & Loeff N.V. are both serving as legal counsel to TJC on the acquisition.

Q4 Inc. Enters into Definitive Agreement to be Acquired by Sumeru Equity Partners

Retrieved on: 
星期一, 十一月 13, 2023
Software, Other Communications, Finance, Public Relations, Investor Relations, Communications, Professional Services, Technology, Fintech, Rolling, Acquisition, Indian stock exchange, Toronto Stock Exchange, Stikeman Elliott, Related, Arrangement, Special, Judgement, Growth, TSX, Model Business Corporation Act, Superior (proposed U.S. state), Gibson Dunn, Disclosure, Minority, Organization, Independent, Q4, Financial assistance (share purchase), Inc., Dorsey & Whitney, Partnership, National instrument, Telephone, The Arrangement, LLP, Immediate, Stifel, Committee, Fairness opinion, Multilateral, Security (finance), Management, Cryptocurrency, Property management, Audit, Lease, Shareholder, Mount Meru, Court

Julie Silcock, Independent Director of the Q4 Inc. Board said, "We are pleased to have reached this agreement with Sumeru Equity Partners, which delivers significant, immediate value to shareholders.

Key Points: 
  • Julie Silcock, Independent Director of the Q4 Inc. Board said, "We are pleased to have reached this agreement with Sumeru Equity Partners, which delivers significant, immediate value to shareholders.
  • Q4 has become a central force in how thousands of public companies communicate and engage with the market.
  • The Q4 Platform, fueled by innovative technology, data, and insights, empowers our customers to communicate their investment story to the world.
  • The process and negotiation of the Arrangement with Sumeru were supervised by a committee of independent directors (the “Special Committee”).

UL Solutions Publicly Files Registration Statement for Proposed Initial Public Offering

Retrieved on: 
星期一, 十一月 13, 2023
Other Consumer, Manufacturing, Women, Cosmetics, Retail, Other Professional Services, Other Technology, Men, Finance, Consulting, Consumer, Professional Services, Department Stores, Consumer Electronics, Technology, Other Energy, Energy, Other Manufacturing, Citigroup, Sale, Bookrunner, Wells Fargo, Telephone, Attention, J. P. Morgan, J.P. Morgan & Co., Bank of America, Form, Jefferies, Prospectus, BofA Securities, UL, UBS, Engagement, Broadridge Financial Solutions, Security (finance), Stifel

UL Solutions Inc. (“UL Solutions”) today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of its Class A common stock.

Key Points: 
  • UL Solutions Inc. (“UL Solutions”) today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of its Class A common stock.
  • The number of shares to be offered and the price range for the proposed offering have not yet been determined.
  • All shares of Class A common stock to be sold in the proposed offering will be sold by UL Standards & Engagement, a nonprofit organization that is currently the sole stockholder of UL Solutions.
  • UL Solutions is not offering any shares of its Class A common stock in the proposed offering and will not receive any proceeds from the proposed sale of the shares.

Thoma Bravo Makes Strategic Investment in BlueMatrix

Retrieved on: 
星期四, 十二月 14, 2023
Research, LLP, Kirkland & Ellis, Gold, Partner, Golub Capital, Workflow, P.C, Thoma Bravo, Growth, Publishing, Cryptocurrency, Renewable energy, Stifel

MIAMI and DURHAM, N.C., Dec. 14, 2023 /PRNewswire/ -- Thoma Bravo, a leading software investment firm, today announced it has signed a definitive agreement to make a strategic growth investment in BlueMatrix, a leading end-to-end content creation and distribution platform for investment research providers. Upon closing of the transaction, Founder and CEO Patricia Horotan will continue to lead the company and will retain a significant ownership position. Terms of the transaction were not disclosed.

Key Points: 
  • MIAMI and DURHAM, N.C., Dec. 14, 2023 /PRNewswire/ -- Thoma Bravo, a leading software investment firm, today announced it has signed a definitive agreement to make a strategic growth investment in BlueMatrix, a leading end-to-end content creation and distribution platform for investment research providers.
  • BlueMatrix is the trusted investment research and publishing platform of choice for many of the world's leading investment banks and research analysts.
  • "We've grown BlueMatrix into the global market leader in end-to-end investment research and publishing solutions, with customers across 70 countries, and are excited to accelerate our strong momentum with capital, operational and strategic support from Thoma Bravo," said Patricia Horotan, CEO of BlueMatrix.
  • "As the gold standard provider of end-to-end investment research and publishing software, BlueMatrix has reimagined the investment research workflow, driving unmatched results for its global portfolio of customers," said Chandler Gay, a Vice President at Thoma Bravo.

Cantor Fitzgerald Bolsters Technology Vertical with Two Senior Hires in Investment Banking and Research

Retrieved on: 
星期三, 十二月 13, 2023
Georgetown University, Research, Thomas Weisel Partners, Senior, Columbia Business School, Cole, Evercore, Morgan Stanley, Stifel, Lehman Brothers, Princeton University, Mergers and acquisitions, Semiconductor, MBA, Cantor Fitzgerald, Investment banking, Research fellow, Business, Barclays, Knowledge, Mergers & Acquisitions, Management, Security (finance), Cantor

NEW YORK, Dec. 13, 2023 /PRNewswire/ -- Cantor Fitzgerald, L.P. ("Cantor"), a leading global financial services firm, today announced the appointments of Cole Bader as Global Head of Technology Investment Banking and C.J. Muse as Senior Managing Director, Semiconductor Analyst. These appointments mark a significant expansion for Cantor in the technology space. Mr. Bader will report directly to Sage Kelly, Global Head of Investment Banking. Mr. Muse will report directly to David Siffringer, Global Head of Equity Research.

Key Points: 
  • Muse joins as Senior Managing Director, Semiconductor Research Analyst
    NEW YORK, Dec. 13, 2023 /PRNewswire/ -- Cantor Fitzgerald, L.P. ("Cantor"), a leading global financial services firm, today announced the appointments of Cole Bader as Global Head of Technology Investment Banking and C.J.
  • Mr. Bader will report directly to Sage Kelly, Global Head of Investment Banking.
  • Sage Kelly, Senior Managing Director and Global Head of Investment Banking, commented on today's announcement, "Cole's extensive experience and proven leadership in the technology investment banking space will strengthen our capabilities and deliver enhanced value to our clients.
  • Mr. Bader's arrival at Cantor is part of a broader initiative, bringing together over 30 technology investment banking professionals to Cantor to develop a newly active industry vertical with a diverse product offering.

INTERNATIONAL BATTERY METALS LTD. ANNOUNCES LIBOR MICHEL AS CO-CEO AND DOUG SMITH AS CFO

Retrieved on: 
星期一, 十二月 11, 2023
Suite, Acquisition, CSE, Interim, CFO, The Company, Jefferies, Insurance, Stifel, Trade in Services Agreement, IBAT, Growth, Lithium, Lowe's Global Technology Center, Transport, Restaurant, Management, Security (finance)

Mr. Michel joins us after a successful investment banking career at Stifel and Jefferies in their Houston offices.

Key Points: 
  • Mr. Michel joins us after a successful investment banking career at Stifel and Jefferies in their Houston offices.
  • Mr. Michel's primary focus will be corporate development and capital markets activity funding the commercialization of the Company's industry leading technologies.
  • Mr. Smith will be responsible for the accounting, audit, tax and financing plans as we mobilize the Company's production facilities.
  • Doug walks in day 1 as a seasoned CFO, with great agility, and adding bench strength to our senior leadership team," said Mr.

Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis

Retrieved on: 
星期四, 十二月 7, 2023
Woman, RMS, Health Canada, Acquisition, Food, Lymphocyte, Psoriasis, Stifel, Ponesimod, FDA, Ulcerative colitis, Multiple sclerosis, Trial of the century, Janssen, Disability, Actelion, Vanda, Pharmaceutical industry

WASHINGTON, Dec. 7, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has acquired U.S. and Canadian rights to PONVORY® (ponesimod) from Actelion Pharmaceuticals Ltd. (Janssen), a Johnson & Johnson Company.

Key Points: 
  • WASHINGTON, Dec. 7, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has acquired U.S. and Canadian rights to PONVORY® (ponesimod) from Actelion Pharmaceuticals Ltd. (Janssen), a Johnson & Johnson Company.
  • PONVORY® is approved by the U.S. Food and Drug Administration (FDA) and Health Canada to treat adults with relapsing forms of multiple sclerosis (RMS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.
  • PONVORY® has a proven safety profile with over 10 years of data.
  • Stifel acted as exclusive financial advisor to Vanda with respect to this acquisition.

NEW STATE CAPITAL PARTNERS ACQUIRES AGILITY RECOVERY SERVICES

Retrieved on: 
星期四, 十一月 30, 2023
Acquisition, Risk management, Morgan, Lewis & Bockius, Insurance, Stifel, Health, Government, Estado Novo, Agility

LARCHMONT, N.Y., Nov. 30, 2023 /PRNewswire/ -- New State Capital Partners ("New State"), a middle-market private equity firm that partners with entrepreneurially minded management teams, announced today its acquisition of Agility Recovery Services ("Agility" or "the Company"). Agility serves as a transformative add-on to New State's existing business continuity platform, which includes AFIMAC Global Inc. ("AFIMAC"), a leading provider of staffing, emergency response, security, and risk management services. Terms of the transaction were not disclosed. New State initially invested in AFIMAC in August 2022.

Key Points: 
  • LARCHMONT, N.Y., Nov. 30, 2023 /PRNewswire/ -- New State Capital Partners ("New State"), a middle-market private equity firm that partners with entrepreneurially minded management teams, announced today its acquisition of Agility Recovery Services ("Agility" or "the Company").
  • Headquartered in Atlanta, GA, Agility Recovery Services has served blue-chip customers in banking, insurance, government, healthcare, and professional services for over three decades.
  • Mr. San Fratello brings over two decades of executive leadership in business services and emergency response to Agility.
  • Morgan, Lewis & Bockius acted as legal advisors, Raymond James provided financial advisory services and Piper Sandler provided debt advisory services to New State.

enGene Appoints Ryan Daws as Chief Financial Officer

Retrieved on: 
星期三, 十一月 29, 2023
Obsidian, BCG, Bachelor of Business Administration, Acquisition, Donald D. Engen, Business development, NMIBC, Therapy, Bachelor, Patient, Business administration, FIDE titles, University, Trial of the century, Growth, Information technology, Business, Initial public offering, Pharmaceutical industry, Science, Stifel

BOSTON and MONTREAL, Nov. 29, 2023 /PRNewswire/ - enGene Holdings Inc. ("enGene,") (NASDAQ: ENGN) (NASDAQ: ENGNW), a clinical-stage genetic medicines company whose lead program is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), today announced the appointment of Ryan Daws as Chief Financial Officer and Head of Business Development.

Key Points: 
  • BOSTON and MONTREAL, Nov. 29, 2023 /PRNewswire/ - enGene Holdings Inc. ("enGene,") (NASDAQ: ENGN) (NASDAQ: ENGNW), a clinical-stage genetic medicines company whose lead program is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), today announced the appointment of Ryan Daws as Chief Financial Officer and Head of Business Development.
  • "I am delighted to welcome Ryan to enGene at a critical time in our growth, as we move forward as a public company and work to advance our ongoing pivotal-stage EG-70 clinical study in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)," said Jason D. Hanson, Chief Executive Officer of enGene.
  • Prior to joining enGene, Mr. Daws was Chief Financial Officer and Head of Business Development at Obsidian Therapeutics, Inc.
  • Mr. Daws also previously served as Chief Financial Officer and Head of Business Development at Concert Pharmaceuticals, Inc.